STRS Ohio’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-24,300
Closed -$807K 2112
2022
Q4
$807K Sell
24,300
-2,300
-9% -$74.1K ﹤0.01% 1035
2022
Q3
$838K Buy
26,600
+10,100
+61% +$327K ﹤0.01% 999
2022
Q2
$501K Buy
16,500
+1,000
+6% +$27K ﹤0.01% 1350
2022
Q1
$402K Buy
+15,500
New +$369K ﹤0.01% 1524
2021
Q2
Sell
-15,100
Closed -$396K 2490
2021
Q1
$396K Sell
15,100
-22,600
-60% -$537K ﹤0.01% 1646
2020
Q4
$704K Hold
37,700
﹤0.01% 1272
2020
Q3
$640K Buy
37,700
+2,900
+8% +$56.4K ﹤0.01% 1190
2020
Q2
$810K Buy
+34,800
New +$504K ﹤0.01% 999
2016
Q1
Sell
-1,100
Closed -$21.7K 1942
2015
Q4
$22K Hold
1,100
﹤0.01% 1850
2015
Q3
$18K Buy
+1,100
New +$20.1K ﹤0.01% 1830
2014
Q2
Sell
-30,135
Closed -$657K 1781
2014
Q1
$657K Sell
30,135
-10,265
-25% -$235K ﹤0.01% 1030
2013
Q4
$1.07M Sell
40,400
-8,300
-17% -$204K ﹤0.01% 708
2013
Q3
$1.15M Sell
48,700
-600
-1% -$14K 0.01% 744
2013
Q2
$1.06M Buy
+49,300
New +$1.06M ﹤0.01% 810

Other funds holding VIVO

STRS Ohio's VIVO Position: Q1 2023 in Review

STRS Ohio sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 24,300 shares — an estimated $807K sold.

STRS Ohio first reported a position in VIVO in Q2 2013 and held it in 14 quarters. The position peaked at $1.15M in Q3 2013. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • STRS Ohio reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • STRS Ohio sold 24,300 Meridian Bioscience Inc shares in Q1 2023, an estimated $807K.
  • STRS Ohio first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 14 quarters.
  • STRS Ohio's Meridian Bioscience Inc position peaked at $1.15M in Q3 2013.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on STRS Ohio's 13F filing for Q1 2023, filed 27 Apr 2023.